Cross-species organ transplantation market analysis with growth outlook
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Cross-Species Organ Transplantation Market In 2026, And How Will Its Value Evolve By 2030?
The cross-species organ transplantation market size has experienced substantial expansion in recent years. This market is projected to expand from $15.2 billion in 2025 to $16.5 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.5%. The historical growth of this market can be primarily attributed to several factors including the scarcity of human donor organs, nascent research initiatives in xenotransplantation, advancements in genetic engineering tools, the preclinical validation of animal-derived organs, and the increasing length of transplant waiting lists.
The cross-species organ transplantation market is projected to experience substantial expansion in the coming years. It is anticipated to reach $22.65 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.2%. This growth over the forecast period is fueled by several factors, including escalating clinical trial activities in xenotransplantation, increased investment in gene-edited animal models, expanding partnerships between biotechnology companies and transplant centers, ongoing progress in immunosuppressive therapies, and the development of broader regulatory frameworks for xenotransplants. Key trends during this period are expected to encompass further advancements in genetically engineered donor organs, a heightened emphasis on strategies to mitigate immune rejection, the proliferation of organ preservation and perfusion technologies, a surge in investment dedicated to translational xenotransplant research, and strengthened regulatory and ethical oversight.
Access Your Free Sample Report For In-Depth Market Analysis:
What Leading Drivers Are Supporting The Cross-Species Organ Transplantation Market Expansion?
The escalating adoption of genetic engineering is anticipated to drive the expansion of the cross-species organ transplantation market. Genetic engineering is defined as the deliberate modification of an organism’s DNA through biotechnology methods to introduce, delete, or alter specific genes. The surge in genetic engineering is attributed to the pressing necessity to overcome organ deficits by creating animal organs with greater compatibility for human transplantation. This approach facilitates the growth of cross-species organ transplantation by enabling the alteration of animal organs to diminish immune rejection, thereby rendering them suitable for human transplants. For instance, in July 2023, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, there were 247 gene therapies in Phase II by the end of first quarter of 2023, increasing by 5% to reach 260 by the end of the second quarter. Consequently, the increasing embrace of genetic engineering is propelling the growth of the cross-species organ transplantation market.
Which Segment Types Are Examined In The Cross-Species Organ Transplantation Market Segment Study?
The cross-species organ transplantation market covered in this report is segmented –
1) By Product Type: Organ Preservation Solution, Transplant Diagnostics, Xeno Products, Other Product Types
2) By Application: Kidney, Heart, Liver, Lung, Other Applications
3) By End-User: Transplant Centers, Hospitals, Other End-Users
Subsegments:
1) By Organ Preservation Solution: Hypothermic Machine Perfusion (HMP) Solutions, Normothermic Machine Perfusion (NMP) Solutions, Static Cold Storage (SCS) Solutions, Oxygenated Perfusion Solutions
2) By Transplant Diagnostics: Histocompatibility Testing, Crossmatching Tests, Molecular Typing (DNA-based Testing), Immunological Monitoring Assays
3) By Xeno Products: Genetically Engineered Donor Organs, Decellularized Organ Scaffolds, Xenogeneic Cellular Therapies, Immunosuppressive Regimens For Xenotransplants
4) By Other Product Types: Organ Transport Devices, Organ Recovery and Preservation Equipment, Surgical Instruments For Transplantation, Post-Transplant Monitoring Devices
What Emerging Trends Are Seen In The Cross-Species Organ Transplantation Market?
Key companies operating within the cross-species organ transplantation market are prioritizing the establishment of strategic partnerships to streamline the regulatory approval procedures for xenotransplantation solutions. A strategic partnership involves companies collaborating to achieve shared objectives by leveraging each other’s strengths and resources, aiming to foster growth, innovation, and competitiveness without a merger. For example, in February 2025, United Therapeutics, a US-based biotechnology company, and eGenesis, a US-based pharmaceutical company, commenced clinical trials for pig kidney (xenotransplant) transplants in humans. This trial received authorization from the U.S. Food and Drug Administration (FDA) to implant genetically modified pig kidneys into patients suffering from kidney failure. The trials endeavor to alleviate the critical shortage of donor kidneys by potentially introducing a new, consistent organ source for individuals requiring them.
Which Players Are Part Of The Competitive Landscape Of The Cross-Species Organ Transplantation Market?
Major companies operating in the cross-species organ transplantation market are Novartis AG, Optipharm Co Ltd, Astellas Pharma Inc., United Therapeutics Corporation, TransMedics Group Inc., Artivion Inc., eGenesis Inc., Organ Recovery Systems Inc., OrganOX Ltd, Paragonix Technologies Inc., Qihan Biotech, PorMedTec Co., XenoTheraputics Inc., Makana Therapeutics Inc., Preservation Solutions Inc., Nzeno Ltd, Infigen Inc., Revivicor Inc., XVIVO Perfusion AB, Bridge To Life Ltd, Transplant Genomics Inc.
Get The Full Cross-Species Organ Transplantation Market Report:
Which Region Is The Largest In The Cross-Species Organ Transplantation Market?
North America was the largest region in the cross-species organ transplantation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cross-species organ transplantation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cross-Species Organ Transplantation Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Cross-Species Organ Transplantation Market 2026, By The Business Research Company
Industrial Laser System Market Report 2026
https://www.thebusinessresearchcompany.com/report/industrial-laser-system-global-market-report
Construction Lasers Market Report 2026
https://www.thebusinessresearchcompany.com/report/construction-lasers-global-market-report
Laser Welding Machine Market Report 2026
https://www.thebusinessresearchcompany.com/report/laser-welding-machine-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
